Abstract:Objective To investigate plasma growth arrest-specific 6 (Gas6) and Omentin-1 levels of type 2 diabetes patients and to explore the relationships of plasma Gas6 and Omentin-1 levels with insulin resistance (IR),obesity and lipid metabolism. Methods The fasting plasma levels of Omentin-1 and Gas6 were detected by enzymelinked immunosorbent assay (ELISA) in 40 T2DM patients with overweight obesity (BMI ≥ 25 kg/m2), 50 T2DM patients with normal weight and 30 normal controls. Meanwhile, data including fasting insulin (Fins), blood glucose and blood lipids were also obtained. The correlations of plasma Gas6 and Omentin-1 levels with those indicators were analyzed. Results Compared with the normal control group, the plasma levels of Gas6 and Omentin-1 were lower in the type 2 diabetes patients (P < 0.05). The plasma Gas6 and Omentin-1 levels of the overweight obesity group were significantly lower than those in the normal weight group and the normal control group (P < 0.05). The serum Gas6 and Omentin-1 levels were positively correlated with HDL-C (P < 0.05), but negatively correlated with HOMA-IR, BMI, TG, TC and LDL-C (P < 0.05). Conclusions The levels of plasma Gas6 and Omentin-1 are associated with insulin resistance, obesity and lipid metabolism, which may contribute to the pathogenesis of type 2 diabetes.BMI, TG, TC and LDL-C (P < 0.05). Conclusions The levels of plasma Gas6 and Omentin-1 are associated with insulin resistance, obesity and lipid metabolism, which may contribute to the pathogenesis of type 2 diabetes.BMI, TG, TC and LDL-C (P < 0.05). Conclusions The levels of plasma Gas6 and Omentin-1 are associated with insulin resistance, obesity and lipid metabolism, which may contribute to the pathogenesis of type 2 diabetes.